Cargando…
Optimal Revascularization Strategy for Patients With ST-segment Elevation Myocardial Infarction and Multivessel Disease: A Pairwise and Network Meta-Analysis
Background: The relative benefit of immediate complete revascularization, staged complete revascularization, and culprit-only percutaneous coronary intervention (PCI) remains unclear in hemodynamically stable patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease. T...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767564/ https://www.ncbi.nlm.nih.gov/pubmed/35071337 http://dx.doi.org/10.3389/fcvm.2021.695822 |
_version_ | 1784634762333257728 |
---|---|
author | Cui, Kongyong Yin, Dong Zhu, Chenggang Yuan, Sheng Wu, Shaoyu Feng, Lei Dou, Kefei |
author_facet | Cui, Kongyong Yin, Dong Zhu, Chenggang Yuan, Sheng Wu, Shaoyu Feng, Lei Dou, Kefei |
author_sort | Cui, Kongyong |
collection | PubMed |
description | Background: The relative benefit of immediate complete revascularization, staged complete revascularization, and culprit-only percutaneous coronary intervention (PCI) remains unclear in hemodynamically stable patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease. The aim of this study was to compare the clinical outcomes of the 3 PCI strategies in this population. Methods: We followed a pre-specified protocol (PROSPERO number: CRD42020183801). A comprehensive search of the electronic databases including PubMed, EMBASE and Cochrane Library from inception through February 21, 2020 was conducted. Randomized trials evaluating the comparative efficacy and safety of at least 2 of the 3 PCI strategies were identified. The primary endpoint was the composite of cardiovascular mortality or myocardial infarction (MI) during the longest follow-up. Pairwise and network meta-analyses were performed with random-effects model. Results: Eleven trials including 6,942 patients were analyzed. Pairwise meta-analysis noted that immediate complete revascularization and staged complete revascularization were respectively associated with a 52 and 27% reduction in the risk of cardiovascular death or MI (relative risk [RR] 0.48, 95% confidence interval [CI] 0.32–0.73, I(2) = 0%; and RR 0.73, 95% CI 0.61–0.88, I(2) = 0%, respectively), compared with culprit-only PCI. The risk of cardiovascular death or MI was not statistically different in staged and immediate complete revascularization groups (RR 0.88, 95% CI 0.45–1.72, I(2) = 0%). Network meta-analysis obtained almost similar results compared with pairwise meta-analysis, and immediate complete revascularization had a 77% probability of being the best strategy for reducing cardiovascular death or MI among the 3 PCI strategies. Conclusion: The current evidence suggests that both immediate and staged complete revascularization were associated with a reduction of cardiovascular death or MI compared with culprit-only PCI. Further trials are warranted to directly compare immediate vs. staged complete revascularization in this population. Systematic Review Registration: https://www.crd.york.ac.uk/prospero/, PROSPERO [CRD42020183801]. |
format | Online Article Text |
id | pubmed-8767564 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87675642022-01-20 Optimal Revascularization Strategy for Patients With ST-segment Elevation Myocardial Infarction and Multivessel Disease: A Pairwise and Network Meta-Analysis Cui, Kongyong Yin, Dong Zhu, Chenggang Yuan, Sheng Wu, Shaoyu Feng, Lei Dou, Kefei Front Cardiovasc Med Cardiovascular Medicine Background: The relative benefit of immediate complete revascularization, staged complete revascularization, and culprit-only percutaneous coronary intervention (PCI) remains unclear in hemodynamically stable patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease. The aim of this study was to compare the clinical outcomes of the 3 PCI strategies in this population. Methods: We followed a pre-specified protocol (PROSPERO number: CRD42020183801). A comprehensive search of the electronic databases including PubMed, EMBASE and Cochrane Library from inception through February 21, 2020 was conducted. Randomized trials evaluating the comparative efficacy and safety of at least 2 of the 3 PCI strategies were identified. The primary endpoint was the composite of cardiovascular mortality or myocardial infarction (MI) during the longest follow-up. Pairwise and network meta-analyses were performed with random-effects model. Results: Eleven trials including 6,942 patients were analyzed. Pairwise meta-analysis noted that immediate complete revascularization and staged complete revascularization were respectively associated with a 52 and 27% reduction in the risk of cardiovascular death or MI (relative risk [RR] 0.48, 95% confidence interval [CI] 0.32–0.73, I(2) = 0%; and RR 0.73, 95% CI 0.61–0.88, I(2) = 0%, respectively), compared with culprit-only PCI. The risk of cardiovascular death or MI was not statistically different in staged and immediate complete revascularization groups (RR 0.88, 95% CI 0.45–1.72, I(2) = 0%). Network meta-analysis obtained almost similar results compared with pairwise meta-analysis, and immediate complete revascularization had a 77% probability of being the best strategy for reducing cardiovascular death or MI among the 3 PCI strategies. Conclusion: The current evidence suggests that both immediate and staged complete revascularization were associated with a reduction of cardiovascular death or MI compared with culprit-only PCI. Further trials are warranted to directly compare immediate vs. staged complete revascularization in this population. Systematic Review Registration: https://www.crd.york.ac.uk/prospero/, PROSPERO [CRD42020183801]. Frontiers Media S.A. 2022-01-05 /pmc/articles/PMC8767564/ /pubmed/35071337 http://dx.doi.org/10.3389/fcvm.2021.695822 Text en Copyright © 2022 Cui, Yin, Zhu, Yuan, Wu, Feng and Dou. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Cui, Kongyong Yin, Dong Zhu, Chenggang Yuan, Sheng Wu, Shaoyu Feng, Lei Dou, Kefei Optimal Revascularization Strategy for Patients With ST-segment Elevation Myocardial Infarction and Multivessel Disease: A Pairwise and Network Meta-Analysis |
title | Optimal Revascularization Strategy for Patients With ST-segment Elevation Myocardial Infarction and Multivessel Disease: A Pairwise and Network Meta-Analysis |
title_full | Optimal Revascularization Strategy for Patients With ST-segment Elevation Myocardial Infarction and Multivessel Disease: A Pairwise and Network Meta-Analysis |
title_fullStr | Optimal Revascularization Strategy for Patients With ST-segment Elevation Myocardial Infarction and Multivessel Disease: A Pairwise and Network Meta-Analysis |
title_full_unstemmed | Optimal Revascularization Strategy for Patients With ST-segment Elevation Myocardial Infarction and Multivessel Disease: A Pairwise and Network Meta-Analysis |
title_short | Optimal Revascularization Strategy for Patients With ST-segment Elevation Myocardial Infarction and Multivessel Disease: A Pairwise and Network Meta-Analysis |
title_sort | optimal revascularization strategy for patients with st-segment elevation myocardial infarction and multivessel disease: a pairwise and network meta-analysis |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767564/ https://www.ncbi.nlm.nih.gov/pubmed/35071337 http://dx.doi.org/10.3389/fcvm.2021.695822 |
work_keys_str_mv | AT cuikongyong optimalrevascularizationstrategyforpatientswithstsegmentelevationmyocardialinfarctionandmultivesseldiseaseapairwiseandnetworkmetaanalysis AT yindong optimalrevascularizationstrategyforpatientswithstsegmentelevationmyocardialinfarctionandmultivesseldiseaseapairwiseandnetworkmetaanalysis AT zhuchenggang optimalrevascularizationstrategyforpatientswithstsegmentelevationmyocardialinfarctionandmultivesseldiseaseapairwiseandnetworkmetaanalysis AT yuansheng optimalrevascularizationstrategyforpatientswithstsegmentelevationmyocardialinfarctionandmultivesseldiseaseapairwiseandnetworkmetaanalysis AT wushaoyu optimalrevascularizationstrategyforpatientswithstsegmentelevationmyocardialinfarctionandmultivesseldiseaseapairwiseandnetworkmetaanalysis AT fenglei optimalrevascularizationstrategyforpatientswithstsegmentelevationmyocardialinfarctionandmultivesseldiseaseapairwiseandnetworkmetaanalysis AT doukefei optimalrevascularizationstrategyforpatientswithstsegmentelevationmyocardialinfarctionandmultivesseldiseaseapairwiseandnetworkmetaanalysis |